Looppatroon analyse na heupprothesiologie Gaitanalysis after Hip prosthesiology
Conditions
Interventions
None listed
Sponsors
Rijnstate Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1: Patient part of randomised controlled trial (RCT) of hip resurfacing versus MoM total hip arthroplasty for symptomatic osteoarthritis of the hip versus total hip arthroplasty 2: Patient must be able to consent to the study (written informed consent) 3: Patients who are functioning well post-operatively and not under routine follow up 4: Patients who are able to walk without any safety rail assistance on the treadmill
Exclusion criteria
Exclusion criteria: 1: Patient not originally randomised during an RCT of hip resurfacing versus MoM total hip arthroplasty. 2: Patients who suffer from any neurological or musculoskeletal conditions that might make a gait test dangerous. 3: Patients whose cognitive function prevents them from understanding the study. 4: Patients who have had or are awaiting revision surgery for their hip
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary objective: The principal objective is to assess top walking speed in patients who have undergone either hip resurfacing arthroplasty or total hip arthroplasty as part of a randomised controlled trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective: 1. The following will also be assessed to determine if there is a difference between patients after resurfacing or total hip arthroplasty: Top walking incline, ability to run, cadence and stride length. 2. Patient-reported outcome measures: Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), EuroQol 5D (EQ-5D), The University of California at Los Angeles (UCLA) activity score will be assessed to establish patient-reported quality of life after surgery. | — |
Countries
Netherlands
Outcome results
None listed